key: cord-0039306-uowqdh4a
authors: Hui, David
title: Cardiology
date: 2010-08-13
journal: Approach to Internal Medicine
DOI: 10.1007/978-1-4419-6505-9_2
sha: c8b6ec6c7e1c8286a83106258b6c69cf8e4cd925
doc_id: 39306
cord_uid: uowqdh4a

• CARDIAC • myocardial—myocardial infarction, angina • valvular—aortic stenosis, aortic regurgitation

pneumomediastinum, pleural effusion, pleuritis VASCULAR-pulmonary embolism, pulmonary hypertension GI-esophagitis, esophageal cancer, GERD, peptic ulcer disease, Boerhaave's, cholecystitis, pancreatitis OTHERS-musculoskeletal, shingles, anxiety PATHOPHYSIOLOGY ANATOMY-layers of aorta include intima, media, and adventitia. Majority of tears found in ascending aorta right lateral wall where the greatest shear force upon the artery wall is produced AORTIC TEAR AND EXTENSION-aortic tear may produce a tearing, ripping sudden chest pain radiating to the back. Aortic regurgitation can produce diastolic murmur. Pericardial tamponade may occur, leading to hypotension or syncope. Initial aortic tear and subsequent extension of a false lumen along the aorta may also occlude blood flow into any of the following vascular structures:

CORONARY-acute myocardial infarction (usually RCA) ABC-O 2 to keep sat >95%, IVs, inotropes, consider balloon pump if hemodynamic instability PAIN CONTROL-nitroglycerin (nitro drip 25 mg in 250 mL D5W, start at 5 mg/min IV, then " by 5-10 mg/ min every 3-5 min to 20 mg/min, then " by 10 mg/ min every 3-5 min , a threshold of 201 pg/mL can be used APPROACH-''the features evaluated in more than one study with the highest LRs (>3.5) for diagnosing heart failure were the following: the overall clinical judgment, history of heart failure, S3, jugular venous distension, pulmonary venous congestion or interstitial edema on CXR, and atrial fibrillation on ECG. The features evaluated in more than one study with the lowest LRs (<0.60) for diagnosing of heart failure were the following: the overall clinical judgment, no prior history of heart failure, no dyspnea on exertion, the absence of rales, and the absence of radiographic pulmonary venous congestion, or cardiomegaly. The single finding that decreased the likelihood of heart failure the most was a BNP <100 pg/mL. While the findings of this study are useful when assessing dyspneic patients suspected of having heart failure, no individual feature is sufficiently powerful in isolation to rule heart failure in or out. Therefore, an overall clinical impression based on all available information is best. If the appropriate constellation of findings with high LRs for heart failure are present, that may be sufficient to warrant empirical treatment without further urgent investigations''

JAMA LVEF <35%, and on maximum treatment already. Caution in elderly and renal failure patients as higher risk of hyperkalemia DIGOXIN (DIG 1997)-hazard ratios for total mortality 0.99 and mortality/hospitalization 0.92. Particularly useful for patients with both HF and atrial fibrillation, or symptomatic HF despite maximum treatment OVERALL APPROACH-treat underlying cause if possible. Non-pharmacological treatments (diet, exercise, smoking cessation) ! add ACE inhibitor for all (or hydralazine/nitrates if renal failure, ARB if cough secondary to ACE inhibitor) ! add b-blocker when euvolemic ! add spironolactone/eplerenone if NYHA III/IV ! add digoxin AE ARB if still symptomatic. If ejection fraction is <30-35% despite optimal medical therapy, consider revascularization, implan- DIGOXIN LEVEL-measurement of serum levels is not routinely necessary as dosing can usually be titrated according to clinical and hemodynamic effects. When measured, serum level should be collected at 12-24 h after the last dose (post-distribution phase). While the upper normal limit is 2.6 nmol/L [2.0 ng/mL], higher digoxin levels may be seen in asymptomatic patients. Low-dose digoxin, resulting in serum levels 0.5-0.9 nmol/L [0.4-0.7 ng/mL] is associated with possible survival benefit compared to !1 nmol/L [!0.78 ng/mL] in HF patients MECHANISM-digitalis acts by inhibiting the membrane-bound Na/K ATPase transport system. This leads to intracellular loss of K and gain of Na. Increase in intracellular Ca leads to " cardiac contractility. Digoxin also exerts a vagotonic action, which slows conduction through the SA and AV node and helps to control heart rate PRECIPITANTS OF DIGOXIN TOXICITY-toxicity is not merely related to serum levels, but also digoxin dosing (e.g. acute overdose), other medications (e.g. non-potassium sparing diuretics), and conditions (e.g. renal insufficiency, acute coronary syndromes, cardiac amyloidosis, hypothyroidism). For instance, hypokalemia, hypernatremia, hypomagnesemia and acidosis predispose to toxicity even at low-serum digoxin levels because of their depressive effects on the Na/K ATPase pump. In contrast, hyperkalemia occurs in acute toxicity and is directly related to prognosis HEART SOUNDS TECHNIQUE-S1, S2, and physiological splitting of S2 are best heard over the base. Identification of S3 and S4 requires conscious effort listening for lowpitched sounds over the apex (using the bell) DISTINGUISHING S1 FROM S2-time with carotid pulse, diastole longer than systole, S2 louder than S1 at the base, S1 is low pitched and longer while S2 is high pitched and shorter, S2 is usually split INTENSITY OF S1 AND S2 LOUD P2 > A2 AT PULMONIC AREA-increased pulmonary pressure (left ventricular failure, mitral stenosis, pulmonary hypertension), increased pulmonary flow (atrial septal defect) LOUD S2 AT AORTIC AREA-hypertension, hyperdynamic states (fever, hyperthyroidism, anemia) SOFT S2 OVER AORTIC AREA-severe aortic stenosis LOUD S1 AT MITRAL AREA-mitral stenosis SOFT S1-mitral High pitch sounds are best heard with the diaphragm, while low pitch sounds are best heard with the bell DISTINGUISHING FEATURES BETWEEN P2 AND OPENING SNAP 1. P2 is best heard at LUSB while opening snap is best heard at the apex 2. P2 separates from A2 on inspiration, while opening snap tends to move closer to S2 on inspiration DISTINGUISHING FEATURES BETWEEN S4 AND S1 1. S4 is usually best heart at apex with the bell while S1 is best heard at base 2. S4 is usually more widely separated from S1 than splitting of S1 3. S4 is loudest at the start of expiration, softest at mid-inspiration 4. S4 may be accentuated by lying down, exercise, or forced inspiration with closed glottis 5. S4 has a lower pitch than S1 DISTINGUISHING FEATURES BETWEEN S3 AND OPENING SNAP 1. S3 has a lower pitch than opening snap 2. S3 occurs later than opening snap DISTINGUISHING FEATURES BETWEEN S3 AND S4 1. S3 has a lower pitch than S4 2. S3 is closer to S2 while S4 is closer to S1 3. Left ventricular S3 is louder at the apex while right ventricular S3 or S4 is usually best heart at left sternal border or at the base MURMURS TIMING MID-SYSTOLIC-aortic stenosis, aortic sclerosis, pulmonary stenosis, hypertrophic obstructive cardiomyopathy, atrial septal defect, flow murmurs (fever, pregnancy, hyperthyroidism, anemia, aortic regurgitation due to high flow) PANSYSTOLIC-mitral regurgitation, tricuspid regurgitation, ventricular septal defect, aortopulmonary shunts LATE SYSTOLIC-mitral valve prolapse, papillary muscle dysfunction EARLY DIASTOLIC-aortic regurgitation, pulmonary regurgitation MID-DIASTOLIC-mitral stenosis, tricuspid stenosis, atrial myxoma, Austin Flint murmur of aortic regurgitation, Carey Coombs murmur of RHD PRE-SYSTOLIC-mitral stenosis, tricuspid stenosis, atrial myxoma CONTINUOUS MURMURS-patent ductus arteriosus, arteriovenous fistula, aortopulmonary connection, venous hum, mammary souffle

INTENSITY-grade I (barely audible), grade II (faint but can be heard immediately), grade III (easily heard), grade IV (loud AND associated with palpable thrill), grade V (very loud, can be heard with the stethoscope half off chest), grade VI (very loud, can be heard with stethoscope off chest wall) QUALITY-depends on the pitch, may be musical, harsh, blowing, rumbling, scratchy, grunting, or squeaky CONFIGURATION-crescendo, decrescendo, crescendo-decrescendo, plateau, holosystolic LOCATION-aortic valve (RUSB), pulmonary valve (LUSB), tricuspid valve (LLSB), mitral valve (apex) RADIATION-aortic valve (carotids), pulmonary valve (left shoulder), tricuspid valve (xyphoid, right of sternum), mitral valve (axilla) MANEUVERS RESPIRATION-right-sided murmurs typically increase with inspiration (except pulmonic click) or sustained abdominal pressure (" venous return), while left-sided murmurs are generally louder during expiration VALSALVA MANEUVER (# venous return and " systemic arterial resistance)-most murmurs decrease in length and intensity during the Valsalva maneuver. Two exceptions are the systolic murmur of hypertrophic cardiomyopathy, which usually becomes much louder, and the systolic murmur of mitral valve prolapse, which becomes longer and often louder (click moves closer to S1) POSITIONAL CHANGES-most murmurs diminish with standing due to reduced preload. However, the murmur of hypertrophic cardiomyopathy becomes louder and the murmur of mitral valve prolapse lengthens and often is intensified. Squatting (or usually passive leg raising, both " venous return and " systemic arterial resistance) produces opposite effect ISOMETRIC EXERCISE (" systemic arterial resistance)-murmurs caused by blood flow across normal or obstructed valves (e.g. mitral or pulmonic stenosis) become louder. Murmurs of mitral and aortic regurgitation and ventricular septal defect also increase with handgrip exercise TRANSIENT ARTERIAL OCCLUSION (" systemic arterial resistance)-transient external compression of both arms by bilateral cuff inflation to 20 mmHg greater than peak systolic pressure augments the murmurs of mitral regurgitation, aortic regurgitation, and ventricular septal defect, but not murmurs due to other causes a Not all findings listed for each condition may be present on examination b Loud heart sounds are usually due to mild-moderate stenotic lesions, while light heart sounds are usually due to regurgitant or severe stenotic lesions c Regurgitant murmurs usually start early, while stenotic murmurs tend to start mid-way d For mitral valve prolapse, maneuvers that increase murmur intensity also move both the click and murmur closer to S1 e For mitral stenosis, the murmur is classically described as mid-diastolic with presystolic accentuation f All the following special signs for aortic regurgitation are related to increased pulse pressure. These include Quincke's pulses (pulsatile fingertips and lips), Becker's sign 

VALVE ABNORMALITY-rheumatic heart disease, infective endocarditis, SLE, calcifications, congenital (bicuspid or unicuspid aortic valve), flail leaflet, osteogenesis imperfecta, drugs (fenfluramine) AORTIC DILATION-aortic dissection, ankylosing spondylitis, syphilis, Marfan's, Ehlers Danlos, hypertension, bicuspid aortic valve, cystic medial necrosis PATHOPHYSIOLOGY PATHOPHYSIOLOGY-leaky aortic valve ! initial compensation with left ventricular dilatation and eccentric hypertrophy (palpitations, atypical chest pain), wide pulse pressure (due to increased stroke volume with elevation in systolic blood pressure and regurgitation with rapid collapse of the arteries and a low diastolic blood pressure) ! eventually decompensation leading to left ventricular dysfunction (heart failure) raised vertically), Corrigan's pulse, Mayne's sign (>15 mmHg decrease in diastolic blood pressure with arm elevation) CARDIAC-soft S1, left-sided S3 (heart failure), diastolic murmur (early diastolic or holodiastolic, blowing, over left upper sternal border), Austin Flint murmur (mid/late diastolic rumble, over apex) and mid-systolic flow murmur OTHERS-Gerhard's sign (systolic pulsations of the spleen), Rosenbach's sign (systolic pulsations of the liver), Traube's sign (pistol shot pulse with systolic and diastolic sounds heard over the femoral arteries), Duroziez's sign (systolic and diastolic bruit heard when the femoral artery is partially compressed), Hill's sign (popliteal cuff systolic pressure exceeding brachial pressure by >60 mmHg STENOTIC MITRAL VALVE-left ventricular inlet obstruction ! left atrial overload and left ventricle output failure ! atrial fibrillation, pulmonary hypertension and eventually right heart failure VALVE AREA-normal 4-5 cm 2 , mild symptoms 1.5-2 cm 2 (mean gradient <5 mmHg), moderate symptoms 1-1.5 cm 2 (mean gradient 5-10 mmHg), severe symptoms <1 cm 2 (mean gradient >10 mmHg)

HISTORY-symptoms related to pulmonary hypertension (dyspnea, hemoptysis, chest pain), symptoms related to right heart failure (hepatomegaly, ascites, edema), hoarseness (Ortner's syndrome, due to enlarged left atrium compressing on recurrent laryngeal nerve), complications (endocarditis, thromboembolism), past medical history (rheumatic fever), medications PHYSICAL GENERAL APPEARANCE-tachypnea, peripheral cyanosis, mitral facies (purple patches on cheeks secondary to vasoconstriction) VITALS-decreased pulse volume JVP-prominent a wave (pulmonary hypertension), absent a wave (atrial fibrillation), cv wave (tricuspid regurgitation) CARDIAC-right ventricular heave, palpable P2 (pulmonary hypertension), loud S1 (valve cusps widely apart at the onset of systole), loud S2, absent S3, opening snap (over apex and left lower sternal border. The earlier the opening snap, the more severe the stenosis), low pitch diastolic rumble (over apex, left decubitus position in expiration) AE pre-systolic accentuation, tricuspid regurgitation ABDOMINAL-hepatomegaly, ascites, edema NODULES (subcutaneous) ERYTHEMA MARGINATUM SYDENHAM CHOREA MINOR CRITERIA-clinical (fever, polyarthralgias), laboratory (" ESR, prolonged PR interval) DIAGNOSIS-either two major criteria or one major criterion and two minor criteria, plus evidence of antecedent streptococcal infection (e.g. positive throat culture or rapid antigen detection test or elevated streptococcal antibody test) INVESTIGATIONS-anti-Streptolysin O antibodies, anti-DNase B, antihyaluronidase, positive throat culture, echocardiogram TREATMENTS-patients with rheumatic disease are at high risk of recurrent rheumatic fever. Recurrent disease causes additional valve damage, and thus these patients should receive prophylaxis for rheumatic fever (penicillin G 1.2 M U IM q4weeks, penicillin V 250 mg PO BID, or erythromycin 250 mg PO BID if allergic to penicillin). For patients with valve involvement, therapy should continue for at least 10 years after the last episode of rheumatic fever and to at least age 40. With a history of carditis in the absence of persistent valvular disease, treat for 10 years or until age 21 (whichever is longer) MANAGEMENT EMPIRIC ANTIBIOTIC THERAPY-native valve and non-IDU (ampicillin 2 g IV q4h or cloxacillin 2 g IV q4h plus gentamicin1 mg/kg IV q8h, or vancomycin1gIVq12h plus gentamicin 1 mg/kg IV q8h), native valve and IDU (cloxacillin 2 g IV q4h plus gentamicin 1 mg/kg IV q8h or vancomycin 1 g IV q12h plus gentamicin 1 mg/kg IV q8h), prosthetic valve (vancomycin 1 g IV q12h plus gentamicin 1 mg/kg IV q8h plus rifampin 600 mg PO daily) TARGETED ANTIBIOTIC THERAPY (please refer to the Sanford guide to antimicrobial therapy)-Streptococci (penicillin G 2-3MU IV q4h or ceftriaxone 2 g IV/IM q24h Â4 weeks. Gentamicin 1 mg/kg IV q24h Â2 weeks may be added in certain circumstances to shorten the course by 2 weeks). Penicillin-sensitive Enterococci (ampicillin 2 g IV q4h or vancomycin 1 g IV q12h Â4-6 weeks, plus gentamicin 1 mg/kg IV q8h Â4-6 weeks for native valve). Penicillin-resistant Enterococci (vancomycin 1 g IV q12h Â6 weeks, plus gentamicin 1 mg/kg IV q8h Â6 weeks for native valve). S. aureus (cloxacillin 2 g IV q6h or nafcillin or oxacillin 3 g IV q6h or cefazolin 2 g IV q8h Â2-6 weeks (depending on right-or leftsided valve) AE gentamicin 1 mg/kg IV q8h Â3-5days: for native valve). MRSA (vancomycin 1 g IV q12h Â6 weeks for native valve). HACEK (ceftriaxone 2 g IV/IM q24h or ampicillin-sulbactam 3 g IV q6h or ciprofloxacin 500 mg PO BID Â4 weeks). For prosthetic valve infection, therapy is usually longer (by 2-4 weeks) with gentamicin SURGERY-valvular replacement (<10% reinfection rate. See indications below)

INDICATIONS FOR SURGERY-in the acute period, refractory congestive heart failure is the most important indication. Other indications include perivalvular extension of infection, abscess, microbiologic failure, infection with fungi or untreatable pathogens, Staphylococci on a prosthetic valve, two major emboli events and one major embolus event with residual large mobile vegetation OVERALL RECOMMENDATIONS FOR ENDOCARDI-TIS PROPHYLAXIS-only given to patients with the highest risk of developing endocarditis, which include the following:

HIGH-RISK CARDIAC CONDITIONS-prosthetic cardiac valve, prosthetic material used for cardiac valve repair, unrepaired cyanotic congenital heart disease, completely repaired cyanotic congenital heart disease with residual defects at the site or adjacent to the site of the prosthetic device, cardiac transplant recipients with valvulopathy, previous endocarditis PROCEDURES ORAL CAVITY-manipulation of gingival or peripical region of teeth, perforation of oral mucosa RESPIRATORY TRACT-tonsillectomy, adenoidectomy, bronchoscopy with a rigid bronchoscope, or flexible bronchoscopy if biopsied GI/GU TRACT-prophylaxis generally not recommended PROPHYLAXIS REGIMENS-give one of the following 30-60 min prior to procedure: amoxicillin 2 g PO/ IM/IV, cefazolin 1 g IV/IM, ceftriaxone 1 g IV/IM, cephalexin 2 g PO, clindamycin 600 mg PO/IM/IV, azithromycin 500 mg PO, clarithromycin 500 mg PO SINUS-P before QRS, QRS after P, P upright II+III, P down aVR. Normal (rate 60-100), tachycardia (rate >100), bradycardia (rate <60), arrhythmia (variable) ATRIAL-rate 60-80 normally, variable P wave, short PR interval JUNCTIONAL (mid and distal region of AV node)rate 40-60, no P wave or inverted P wave VENTRICULAR (His bundle, bundle branches, ventricle)-rate 20-40, no P wave TACHYCARDIA REGULAR NARROW COMPLEX TACHYCARDIAsinus tachycardia, atrial flutter with fixed block (rate 300, 150, 100, 75, 60), supraventricular tachycardia (atrial tachycardia, AV nodal reentry, AV reentrant/ WPW orthodromic conduction), accelerated junctional tachycardia IRREGULAR NARROW COMPLEX TACHYCARDIAsinus tachycardia/arrhythmia, premature atrial contractions, multifocal atrial tachycardia, ectopic atrial tachyarrhythmia with variable block, atrial flutter with variable block, atrial fibrillation REGULAR WIDE COMPLEX TACHYCARDIA-ventricular tachycardia, accelerated idioventricular rhythm, regular narrow complex tachycardia with aberrant conduction, pacemaker-mediated tachyarrhythmia, WPW with antidromic conduction IRREGULAR WIDE COMPLEX TACHYCARDIAcoarse ventricular fibrillation, polymorphic ventricular tachycardia, atrial fibrillation with WPW (anterograde conduction), irregular narrow complex tachycardia with aberrant conduction DISTINGUISHING FEATURES SUGGESTIVE OF VT RATHER THAN SVT WITH ABERRANT CONDUC-TION-older age, history of coronary artery disease, AV dissociation (dissociated P waves, fusion beats, capture beats), concordance of precordial leads, QRS width >160 ms in LBBB or >140 ms in RBBB, atypical BBB, extreme LAD (-908 to -1808) BRADYCARDIA AND PROLONGED PR SINUS-sinus bradycardia, sick sinus syndrome with sinus pause, bradycardia-tachycardia syndrome (SSS+AF usually) AV BLOCK-prolonged PR interval FIRST DEGREE-PR >200 ms constantly SECOND DEGREE MOBITZ TYPE I (Wenckebach)-PR progressively longer and then dropped QRS MOBITZ TYPE II-PR constant and then sudden dropped QRS. When any but not all ventricular beats are dropped, second degree block exists THIRD DEGREE-complete blockage with independent atrial and ventricular rhythms PROLONGED QRS-BUNDLE BRANCH BLOCK AND HEMIBLOCK ANATOMY-SA node (RCA 59%, LAD 38%, both 3%) ! AV node (RCA 90%, LCX 10%) ! bundle of His (RCA) ! right bundle (LAD), left anterior fascicle (LAD, RCA), and left posterior fascicle (RCA, LAD) RBBB-QRS >120 ms, slurred S wave in I and V6 and rSR' in V1-3 with R' taller than r. May also see QR' complex in V1 (suggestive of old or new infarct). QRS polarity positive in V1-2. Causes include LAD involvement/anterior infarction, may be benign in young people LBBB-QRS >120 ms, broad monomorphic R in I and V6, with no Q waves, broad monomorphic S in V1, may have small r wave. QRS polarity negative in V1-2. Causes include hypertension, CAD, dilated cardiomyopathy, rheumatic heart disease, infiltrative diseases, benign or idiopathic LEFT ANTERIOR HEMIBLOCK-QRS 100-120 ms, left axis deviation -308 to -908, qR in I, rS in III, II, and aVF. May be benign, LAD involvement/anterior infarction. Shortcut to diagnosis-I up, II down, aVF down LEFT POSTERIOR HEMIBLOCK-right axis deviation 90-1808, normal or slightly widened QRS, rS in I, and qR in III. RCA involvement/anterior infarction BIFASCICULAR BLOCK-RBBB+LAHB, RBBB+LPHB TRIFASCICULAR BLOCK-first degree AV block + bifascicular block PROLONGED QT NORMAL-QTc=square root (QT in seconds/RR interval in seconds); QT <50% of RR interval; normal QTc 390-460ms (women), 390-450 ms (men) CAUSES-genetic, metabolic (hypokalemia, hypomagnesemia, hypocalcemia), antiarrhythmics (quinidine, procainamide, amiodarone, sotalol), antibiotics (macrolide, trimethoprim-sulfamethoxazole, fluoroquinolone), psychotropics (TCA, SSRI, haloperidol, risperidone), analgesics (methadone), structural heart disease (HF, LVH, acute ischemia), others (HIV, anorexia nervosa, stroke, brain injury) PROGRESSION-may evolve into torsade de pointes, VT, and sudden death (amiodarone less likely) TREATMENTS-remove offending agent(s), overdrive pacing, isoproterenol infusion, magnesium HYPERTROPHY CRITERIA RAE-tall peaked P in II and aVF (>2.5 mm high); large initial component of biphasic P in V1 LAE-wide notched P in II (>2.5 mm long); biphasic P in V1 with broad negative phase; P wave duration >120 ms LVH-tall R in aVL (>11 mm); R in V5 or V6 (whichever is taller) plus S in V1 >35 mm; R in V5 or R in V6 >27 mm; poor R wave progression in precordial leads; ST depression and T wave inversion in lateral leads (I, aVL, V5-6) suggestive of ventricular strain; R in aVL plus S in V3 >28 mm in male or >20 mm in female (Cornell criteria). Diagnosis difficult with LBBB, consider LVH if S in V1 + R in V5 >45 mm (Klein criteria) RVH-right axis deviation (>1108); R>S wave in V1 and R >7 mm; persistent S waves V5-6; ST depression and T wave inversion V1-3 DIFFERENTIAL DIAGNOSIS FOR DOMINANT R WAVE IN V1-RV hypertrophy, right bundle branch block, posterior myocardial infarction, pre-excitation (Wolff-Parkinson-White), dextrocardia, Duchenne muscular dystrophy, hypertrophic cardiomyopathy, normal variant, incorrect lead placement, juvenile pattern 

RHYTHM-regular/irregular, wide/narrow complex, sinus, atrial, atrioventricular

PR INTERVAL-normal 120-200 ms; first, second, third degree AV block

QRS INTERVAL-normal 80-110 ms, intraventricular conduction delay 110-120 ms

atherosclerosis, uncontrolled hypertension, flash pulmonary edema, asymmetrical kidneys, renal failure with ACE inhibitor, and renal bruits DIAGNOSIS-MR angiogram (preferred as non-invasive and high sensitivity/specificity), CT angiogram, duplex U/S (anatomic and functional information), captopril-enhanced radioisotope renogram (functional scan but out-of-fashion), contrast angiogram (gold standard) TREATMENTS-medical (risk factor reduction with emphasis on blood pressure control. ACE inhibitors/ARBs are particularly useful in renal artery stenosis, but should be used with caution in severe bilateral renal artery stenosis. Diuretics should be added if hypertension persists), angioplasty (consider if severe or refractory hypertension, recurrent flash pulmonary edema, acute significant decline in renal failure due to renal artery stenosis. Unlikely to reverse renal failure if small kidneys or high creatinine >300 mmol/L [3. Systolic bruit 78% 64% 2.1 3.5 APPROACH-''given the high prevalence (7-31%) of innocent abdominal bruits in the younger age groups, it is recommended that if a systolic abdominal bruit is detected in a young, normotensive, asymptomatic individual, no further investigations are warranted. In view of the low sensitivity, the absence of a systolic bruit is not sufficient to exclude the diagnosis of renovascular hypertension. In view of the high specificity, the presence of a systolic bruit (in particular a systolic-diastolic bruit) in a hypertensive patient is suggestive of renovascular hypertension. In view of the lack of evidence to support characterizing bruits as to pitch, intensity and location, bruits should be reported only as systolic or systolic/diastolic'' JAMA COPD-RAD, # amplitude, multifocal atrial tachycardia HYPERCALCEMIA-short QT HYPOCALCEMIA-prolonged QT WOLFF-PARKINSON-WHITE SYNDROME-short PR (<120 ms), delta wave, prolonged QRS (>120 ms), symptomatic tachycardia. Pharmacological treatments include amiodarone and procainamide. AV nodal blocking drugs (adenosine, bblockers, verapamil/diltiazem, digoxin) are contraindicated in patients with WPW and AF as they may precipitate VF. Consider catheter ablation if symptomatic arrhythmias, AF, or atrial flutter. If failed, consider surgical ablation Approach to ECG